ZS Pharma Inc., IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
ZS Pharma Inc., | ZSPH - NASDAQ |
$15.00-$17.00 |
$18.00 |
$27.21 | 5.9 million | 6/18/2014 |
J.P. Morgan, Credit Suisse |
Co-Manager(s): BMO Capital Markets, William Blair |
Health Care |
Filing(s): Filed 2014-05-15 Terms Added 2014-06-06
|
For IPO Boutique's "scale of 1 to 5" BUY rating on ZS Pharma Inc.,, and our comprehensive analysis, click "Buy Market Research".
ZS Pharma Inc., Quote & Chart - Click for current quote -
ZSPH
About ZS Pharma Inc., (adapted from ZS Pharma Inc., prospectus):
They are a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.
This description is adapted from ZS Pharma Inc., prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as ZS Pharma Inc., "ZSPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved